Skip to content
Monday, December 2, 2024
Wall Street Insider
Deliver critical advise to busy investors
Search
Search
News
About Us
Services
Institutional Research
Portfolio Analysis
#1 Stock Pick
Subscriptions
Contact Us
CLIENT LOGIN
Home
News
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
News
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
November 5, 2024
Arthur Bleemer
Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales forecast higher, as its efforts to offer more personalized care and more weight-loss drugs continue to draw subscribers.
Read more from source
Post navigation
Dollar Tree’s CEO steps down. An analyst says the move comes at a ‘difficult time.’
Marqeta’s stock may shed a third of its value as these factors spur weak outlook